title: Structure-activity studies of divin: an inhibitor of bacterial cell division.
abstract: We describe the synthesis and SAR studies of divin-a small molecule that blocks bacterial division by perturbing the assembly of proteins at the site of cell septation. The bacteriostatic mechanism of action of divin is distinct from other reported inhibitors of bacterial cell division and provides an opportunity for assessing the therapeutic value of a new class of antimicrobial agents. We demonstrate a convenient synthetic route to divin and its analogs, and describe compounds with a 10-fold increase in solubility and a 4-fold improvement in potency. Divin analogs produce a phenotype that is identical to divin, suggesting that their biological activity comes from a similar mechanism of action. Our studies indicate that the 2-hydroxynaphthalenyl hydrazide portion of divin is essential for its activity and that alterations and substitution to the benzimidazole ring can increase its potency. The SAR study provides a critical opportunity to isolate drug resistant mutants and synthesize photoaffinity probes to determine the cellular target and biomolecular mechanism of divin.
authors.affiliation: Department of Biochemistry, University of Wisconsin-Madison, Madison, WI 53706 USA.
authors.forename: Maoquan
authors.initials: M
authors.lastname: Zhou
authors.forename: Ye-Jin
authors.initials: YJ
authors.lastname: Eun
authors.forename: Ilia A
authors.initials: IA
authors.lastname: Guzei
authors.forename: Douglas B
authors.initials: DB
authors.lastname: Weibel
keywords: SAR; antimicrobial; divin; synthesis
references.citation: J Am Chem Soc. 2012 Jul 18;134(28):11322-5
references.pmid: 22741745
references.citation: Biochemistry. 2011 Sep 13;50(36):7719-34
references.pmid: 21823588
references.citation: J Am Chem Soc. 2013 Jul 3;135(26):9768-76
references.pmid: 23738839
references.citation: Nat Rev Drug Discov. 2011 Jun 24;10(7):507-19
references.pmid: 21701501
references.citation: Adv Drug Deliv Rev. 2001 Mar 1;46(1-3):3-26
references.pmid: 11259830
references.citation: J Pharm Biomed Anal. 2006 Oct 11;42(4):449-54
references.pmid: 16797909
references.citation: ACS Chem Biol. 2012 Nov 16;7(11):1918-28
references.pmid: 22958099
references.citation: Nat Protoc. 2007;2(6):1414-25
references.pmid: 17545978
references.citation: Antimicrob Agents Chemother. 2008 Sep;52(9):3339-49
references.pmid: 18625781
references.citation: Bioorg Med Chem. 2009 Jan 15;17(2):641-52
references.pmid: 19110434
references.citation: Nature. 2010 Aug 19;466(7309):935-40
references.pmid: 20686482
references.citation: Clin Microbiol Rev. 2011 Jan;24(1):71-109
references.pmid: 21233508
references.citation: J Antimicrob Chemother. 2000 Oct;46(4):523-6
references.pmid: 11020247
references.citation: ACS Med Chem Lett. 2011 Apr 14;2(4):289-292
references.pmid: 21552338
references.citation: Nat Rev Microbiol. 2011 Jan;9(1):62-75
references.pmid: 21164535
references.citation: Eur J Med Chem. 2010 Jun;45(6):2345-52
references.pmid: 20207453
references.citation: J Med Chem. 2012 May 24;55(10):4527-38
references.pmid: 22409666